Evidence 1
Activity
Activity
0% Hemolysis
Toxicity
50 µg/mL
Hemolytic
Cytotoxic
0% Hemolysis | 50 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Modification of a synthetic antimicrobial peptide (ESF1) for improved inhibitory activity. | Biochem Biophys Res Commun | 1998